Cooper C. Collins's Net Worth

$20.7 Million

Estimate Recalculated Sep 9, 2024 12:27AM EST

Who is Cooper C. Collins

Cooper C. Collins has an estimated net worth of $20.7 Million. This is based on reported shares across multiple companies, which include TherapeuticsMD, Inc., and PERNIX THERAPEUTICS HOLDINGS, INC..

SEC CIK

Cooper C. Collins's CIK is 0001485508

Past Insider Trading and Trends

2021 was Cooper C. Collins's most active year for acquiring shares with 5 total transactions. Cooper C. Collins's most active month to acquire stocks was the month of May. 2013 was Cooper C. Collins's most active year for disposing of shares, totalling 15 transactions. Cooper C. Collins's most active month to dispose stocks was the month of September. 2021 saw Cooper C. Collins paying a total of $1,303,500.00 for 2,196,038 shares, this is the most they've acquired in one year. In 2014 Cooper C. Collins cashed out on 3,860,000 shares for a total of $13,103,902.88, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TherapeuticsMD, Inc.

Investor
Updated Aug 26, 2024
Form 4
8.54%
4.09K
$1.73
$7.10K
Aug 26, 2024
52.02K
Purchase
Aug 22
Form 4
2.57%
1.20K
$1.70
$2.04K
Aug 23, 2024
47.92K
Purchase
Aug 21
Form 4
8.50K
Jul 19, 2023
8.50K
Grant
Jul 17
Form 4
5.00K
Oct 03, 2022
5.00K
Grant
Sep 29
Form 4
Aug 22, 2022
46.72K
Options
Aug 18
Form 4
80.85%
1.00M
$0.58
$578.50K
Nov 22, 2021
2.24M
Purchase
Nov 18
Form 4
422.18%
1.00M
$0.73
$725.00K
Aug 19, 2021
1.24M
Purchase
Aug 17 - Aug 18
Form 4
Aug 12, 2021
236.86K
Options
Aug 10
Form 4
99.17K
Jul 02, 2021
99.17K
Grant
Jul 01
Form 4
96.86K
Jun 19, 2020
96.86K
Grant
Jun 18
Form 4
112.12%
74.00K
$1.45
$107.30K
Jun 10, 2020
140.00K
Purchase
Jun 08 - Jun 09
Form 4
75.00K
Jun 24, 2019
75.00K
Grant
Jun 20
Form 4
83.33%
30.00K
$3.33
$99.87K
May 15, 2019
66.00K
Purchase
May 13
Form 4
50.00K
Jul 05, 2018
50.00K
Grant
Jul 02
Form 4
50.00K
Jun 23, 2017
50.00K
Grant
Jun 21
Form 4
25.00K
Dec 22, 2016
25.00K
Grant
Dec 21
Form 4
80.00%
16.00K
$6.23
$99.72K
Mar 14, 2016
36.00K
Purchase
Mar 11
Form 4
50.00K
Dec 21, 2015
50.00K
Grant
Dec 17
Form 4
100.00K
Mar 26, 2015
100.00K
Grant
Mar 25
Form 4
20.00K
$3.84
$76.89K
Jun 09, 2014
20.00K
Purchase
Jun 05
Form 4
46.67%
70.00K
Jan 08, 2014
220.00K
Options
Jan 06
Form 4
-100.00%
-2.63M
$1.75
-$4.61M
Jun 17, 2013
Sale
Jun 14
Form 4
100.00%
75.00K
May 03, 2013
150.00K
Grant
May 01
Form 4
75.00K
Apr 17, 2012
75.00K
Grant
Apr 16
Form 3
Mar 02, 2012
2.63M
Showing 25 results

PERNIX THERAPEUTICS HOLDINGS, INC.

Chief Strategic Officer
Updated Apr 02, 2014
Form 4
-3.47%
-90.00K
$5.26
-$473.08K
Apr 02, 2014
3.53M
Sale
ScheduledApr 01 - Apr 02
Form 4
-58.09%
-3.59M
$3.40
-$12.22M
Mar 05, 2014
3.62M
Sale
ScheduledMar 03 - Mar 04
Form 4
-1.44%
-90.00K
$2.22
-$199.72K
Feb 05, 2014
7.21M
Sale
ScheduledFeb 03 - Feb 05
Form 4
-0.44%
-27.96K
$2.20
-$61.61K
Jan 08, 2014
7.30M
Sale
ScheduledJan 07
Form 4
-0.98%
-62.04K
$2.35
-$145.71K
Jan 06, 2014
7.32M
Sale
ScheduledJan 02 - Jan 06
Form 4
-0.59%
-37.45K
$2.31
-$86.63K
Dec 10, 2013
7.39M
Sale
ScheduledDec 05 - Dec 06
Form 4
-0.81%
-52.55K
$2.44
-$128.21K
Dec 04, 2013
7.42M
Sale
ScheduledDec 02 - Dec 04
Form 4
-1.38%
-90.00K
$2.01
-$180.61K
Nov 05, 2013
7.48M
Sale
ScheduledNov 01 - Nov 05
Form 4
-0.36%
-23.36K
$2.47
-$57.73K
Oct 08, 2013
7.57M
Sale
ScheduledOct 04 - Oct 08
Form 4
-1.01%
-66.64K
$2.55
-$169.74K
Oct 03, 2013
7.59M
Sale
ScheduledOct 01 - Oct 03
Form 4
-15.86%
-1.25M
$4.04
-$5.05M
Jul 25, 2013
7.66M
Disposition
Jul 24
Form 4
-5.30%
-498.43K
$7.00
-$3.49M
Jul 25, 2011
8.91M
Sale
Jul 21
Form 4
9.40M
Mar 11, 2010
9.41M
Grant
Mar 09
Form 3
Mar 11, 2010
Showing 14 results